USDA Federal Research ARS ยท APHIS ยท NASS โ€” Bee health economics data connected USDA Priority โ€” Pollinator Health Economic Analysis
One Farmer. One Stack.
SF29-E ยท Honey Bee Health Economics ยท Patent Pending US 63/970,943

๐Ÿ’ฐ Honey Bee Health Economics

AFB vaccine program ROI, colony loss prevention value, biosecurity investment payback, vaccine vs antibiotic economics, pollination contract protection ROI, and apiary-scale vaccination program analysis.

SF29-E.001 AFB Vaccine ROISF29-E.002 Colony Loss PreventionSF29-E.003 Biosecurity PaybackSF29-E.004 Vaccine vs AntibioticSF29-E.005 Pollination Contract ROISF29-E.006 Apiary Vaccination Program
โšก
Fetch NASS & Apiary Data Load honey prices & colony value benchmarks
๐Ÿ”ฌ
Science SF29 AFB risk & colony survival science
๐Ÿ’ฌ
Chat Mode AI-guided calculation
SF29-E.001

๐Ÿ’‰ AFB Vaccine Program ROI

Calculate the full return on investment of an AFB vaccination program versus oxytetracycline antibiotic treatment. Includes drug costs, labor, treatment frequency, resistance risk, and organic market premium impact.

Full 2-dose Dalan protocol per colony
Oxytetracycline treatment cost including labor
Cost to replace a lost colony (package + queen)
Typical range 3โ€“15% in active outbreak regions
Published Dalan conditional approval efficacy: ~56%
SF29-E.002

๐Ÿ Colony Loss Prevention Value

Quantify the total financial value of preventing colony losses through vaccination. Includes honey production revenue, pollination contract value, colony replacement cost, and apiary reputation protection.

0 if hobbyist/no pollination contracts
SF29-E.003

๐Ÿ›ก๏ธ Biosecurity Investment Payback

Calculate the payback period and ROI of a full apiary biosecurity upgrade โ€” vaccination, hygienic queen replacement, equipment sanitization, and inspection protocol investment โ€” versus reactive loss management.

Total for all colonies including labor
One-time upgrade to certified hygienic stock
Annual scorching, wax moth treatment, cleaning
Typical range 45โ€“75% with full protocol
SF29-E.004

โš–๏ธ Vaccine vs Antibiotic Economics

Direct cost comparison of AFB vaccination versus oxytetracycline antibiotic program over a 5-year horizon. Includes resistance development risk, organic certification premium impact, and regulatory compliance trajectory.

Organic honey commands $2โ€“5/lb premium over conventional
Increasing treatment failure rates and retreatment costs
SF29-E.005

๐ŸŒธ Pollination Contract Protection ROI

Calculate the ROI of vaccination in protecting pollination contract revenue. Models contract penalty avoidance, colony delivery guarantee value, grower relationship lifetime value, and contract renewal premium from disease-free status.

Typical penalty clause: 15โ€“25% of contract value
SF29-E.006

๐Ÿ“Š Apiary-Scale Vaccination Program

Full apiary-scale vaccination economics model. Calculate total program cost, net benefit over 3 years, cost per colony saved, break-even colony count, and ROI across small, medium, and commercial apiary sizes.

Honey + pollination combined

๐Ÿ’ฐ About SF29 Economics โ€” Honeybee Health & Vaccine Economics

These 6 economics calculators are the financial complement to the ๐Ÿ”ฌ Science Calculators โ†’ Each pairs directly with its scientific model to translate AFB risk scores, vaccine efficacy data, and biosecurity assessments into revenue impact, ROI, and payback analysis.

Together they provide beekeepers, commercial apiaries, and pollination service providers with a complete cost-benefit framework for the world's first conditionally approved honey bee vaccine โ€” built on Dalan Animal Health research and USDA-ARS pollinator science.

๐Ÿข
Powered by Dalan Research ยท Dalan Animal Health ยท Athens, Georgia Dalan Animal Health is a pioneering animal health biotech developing vaccines across multiple species โ€” including the world's first conditionally approved USDA vaccine for honey bees against American Foulbrood (Paenibacillus larvae), as well as vaccine programs for shrimp and other aquatic and invertebrate species. AgrStak's SF29 platform translates Dalan's honey bee vaccine research into economic decision support for beekeepers and commercial apiary operators. Research sources: Dalan Animal Health (2023), USDA-ARS Bee Research Laboratory, Bee Informed Partnership (2024) annual loss survey, USDA-NASS Honey Reports, and peer-reviewed apiculture economics literature.